Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)
0.2000 x 2000 0.2100 x 13000
Post-market by (Cboe BZX)
0.2000 unch (unch) 02/28/25 [CNSX]
0.2000 x 2000 0.2100 x 13000
Post-market 0.2000 unch (unch) 11:30 ET
Quote Overview for Fri, Feb 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.2000
Day High
0.2150
Open 0.2100
Previous Close 0.2000 0.2000
Volume 157,800 157,800
Avg Vol 122,345 122,345
Stochastic %K 45.45% 45.45%
Weighted Alpha -36.90 -36.90
5-Day Change -0.0200 (-9.09%) -0.0200 (-9.09%)
52-Week Range 0.1600 - 0.3300 0.1600 - 0.3300
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 58,023
  • Shares Outstanding, K 290,115
  • Annual Sales, $ 13,657 K
  • Annual Income, $ -4,700 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.92
  • Price/Sales 1.32
  • Price/Cash Flow N/A
  • Price/Book 7.80

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1600 +25.00%
on 01/31/25
Period Open: 0.1700
0.2300 -13.04%
on 02/24/25
+0.0300 (+17.65%)
since 01/28/25
3-Month
0.1600 +25.00%
on 01/31/25
Period Open: 0.2300
0.2300 -13.04%
on 02/24/25
-0.0300 (-13.04%)
since 11/28/24
52-Week
0.1600 +25.00%
on 01/31/25
Period Open: 0.3250
0.3300 -39.39%
on 05/09/24
-0.1250 (-38.46%)
since 02/28/24

Most Recent Stories

More News
Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete an...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma Granted First Patent in India for its Liposomal CBD Injection

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60

/CNW/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma Announces Private Placement of Units

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete a...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)
Innocan Pharma Reports Third Quarter 2024 Financial Results

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.2000 (unch)
INNPF : 0.1143 (-4.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue...

See More

Key Turning Points

3rd Resistance Point 0.2250
2nd Resistance Point 0.2200
1st Resistance Point 0.2100
Last Price 0.2000
1st Support Level 0.1950
2nd Support Level 0.1900
3rd Support Level 0.1800

See More

52-Week High 0.3300
Fibonacci 61.8% 0.2651
Fibonacci 50% 0.2450
Fibonacci 38.2% 0.2249
Last Price 0.2000
52-Week Low 0.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements